"The Report EpiCast
Report: Non-Hodgkin’s Lymphoma - Epidemiology Forecast to 2024
provides information on pricing, market analysis, shares, forecast,
and company profiles for key industry participants. -
MarketResearchReports.biz"
MarketResearchReports.biz has
added a new research report, titled “EpiCast Report: Non-Hodgkin’s
Lymphoma
- Epidemiology Forecast To 2024,” to its vast database. The
research report on non-Hodgkin lymphoma or NHL explains the nature of
the disease with a complete chapter on its epidemiology. This chapter
explains the patterns, causes, and effects of NHL on the overall
health of the patient. It also studies the background of the disease
and risk factors.
Non-Hodgkin lymphoma is a type of
cancer that starts in cells called lymphocytes, which are an integral
part of the human immune system. Lymphocytes are found in the lymph
nodes and other lymphoid tissues such as in bone marrow and the
spleen. Non-Hodgkin lymphoma (NHL) is a group of blood cancers that
develop in the lymphatic system. This disease negatively impacts the
immune system with an uncontrollable growth of malignant white blood
cells, which, over a period of time, depletes the body’s ability to
fight against infections and other incursions. So far, NHL has been
categorized into three types, namely, T-cell, B-cell, and natural
killer lymphocyte lymphomas.
The report on NHL sheds light on
the four subtypes of B-cell NHL, namely, diffuse large B-cell
lymphoma (DLBCL), marginal zone lymphoma, follicular lymphoma, and
mantle cell lymphoma. Research suggests that occurrence of NHL is
common amongst white men than in women and its chances increase with
age.
According to the forecast
published in the research report, the number of B-cell NHL cases in
the 7MM, namely France, Germany, Italy, Japan, Spain, the UK and the
US, was 104,854 in 2014 and is expected to reach 129,179 by 2024.
This growth will be registered at an annual growth rate of 2.32% from
2015 to 2024. Of all these regions, the US will witness the highest
number of B-cell NHL cases. This region alone is expected to have a
growth rate of 36% all through 2024 to reach a figure of 57,724.
Furthermore, each of the aforementioned countries will witness a rise
in the number of cases in the coming 10 years.
To analyze the growing incidence
of NHL, epidemiologists have collated data from peer-reviewed
journals, new items, and country-specific disease databases to create
a well-researched document for the readers. The report offers a
detailed 10-year forecast of the NHL cases of marginal zone lymphoma,
mantle cell lymphoma, follicular lymphoma, and DLBCL in the seven
major markets of the world.
View Press Release @
http://www.marketresearchreports.biz/pressrelease/625
The country-specific analysis of
NHL helps in establishing a meaningful comparison of the elements
influencing the B-cell NHL incidence in the 7MM. Additionally, the
research report also provides a segmentation of the disease on the
basis of age, sex, and the sub-types, thereby highlighting the
proliferation of B-cell NHL research and market growth in the major
markets.
About us
MarketResearchReports.biz
is the most comprehensive collection of market research reports.
MarketResearchReports.Biz services are specially designed to save
time and money for our clients. We are a one stop solution for all
your research needs, our main offerings are syndicated research
reports, custom research, subscription access and consulting
services. We serve all sizes and types of companies spanning across
various industries.
Contact
Mr.
Nachiket
State
Tower
90
Sate Street, Suite 700
Albany,
NY 12207
Tel:
+1-518-621-2074
No comments:
Post a Comment